Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 0.4136
-5.52 %
$ 60.6 M
Market Cap
-1.36
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Biodesix, Inc.
| Revenue | 71.3 M |
| Cost Of Revenue | 15.6 M |
| Gross Profit | 55.8 M |
| Operating Expenses | 90.2 M |
| Operating Income | -34.5 M |
| Other Expenses | 8.43 M |
| Net Income | -42.9 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 71.3 | 49.1 | 38.2 | 54.5 | 45.6 | 24.6 | 20.4 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 15.6 | 13.0 | 14.2 | 30.5 | 22.0 | 6.1 | 4.4 |
| Gross Profit | 55.8 | 36.1 | 24.1 | 24.0 | 23.6 | 18.5 | 16.0 |
| OPERATING INCOME | |||||||
| Operating Expenses | 90.2 | 77.4 | 74.6 | 63.3 | 45.7 | 41.1 | 34.1 |
| Selling, General and Administrative Expenses | 80.5 | 67.4 | 61.5 | 50.5 | 34.9 | 30.6 | 25.9 |
| Research and Development Expenses | 9.6 | 10.0 | 13.1 | 12.8 | 10.8 | 10.5 | 8.2 |
| Operating Income | (34.5) | (41.3) | (50.5) | (39.3) | (22.1) | (22.6) | (23.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 8.3 | 9.5 | 8.1 | 4.5 | 7.6 | 3.0 | 2.9 |
| Total Other Income | (8.4) | (10.8) | (14.9) | (2.2) | (8.4) | (4.0) | (2.7) |
| Pre-Tax Income | (42.9) | (52.1) | (65.4) | (43.2) | (31.4) | (30.7) | (26.2) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | 14.9 | 1.3 | 5.1 | 0.6 | 0.2 |
| Net Income | (42.9) | (52.1) | (80.4) | (44.5) | (36.5) | (31.4) | (26.2) |
| EPS | 0.33 | 0.64 | 1.91 | 1.63 | 1.37 | 1.23 | 0.99 |